Drugs / UMSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07240987 | Jan 2026 → Aug 2027 expected | diabetic kidney disease, hypertensive nephropathy | The First Affiliated Hospital of Air Force Medicial University | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UMSCs | “intravenous injection of umbilical cord tissue derived mesenchymal stem cells (UMSCs) on the improvement of renal function in patients with chronic kidney disease (CKD) at stage 3 or 4” NCT07240987 ↗ |
| Known as | MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07240987 ↗ |
| Modality | Cell therapy | “umbilical cord tissue derived mesenchymal stem cells (UMSCs)” NCT07240987 ↗ |
| Route | Intravenous | “The experimental group will receive an intravenous injection of allogeneic MSCs” NCT07240987 ↗ |